Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Paroxetine I.P. 12.5mg Prolonged Release Tablets
Therapeutic Category
Antidepressant, Neurology, Sedative or Antianxiety
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹189/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Paroxyle 12.5 CR contains Paroxetine I.P. 12.5mg in a prolonged-release (CR) formulation, designed for the gradual release of the active ingredient over an extended period. This allows for consistent therapeutic effects and helps reduce side effects associated with peak drug levels. Paroxetine is a selective serotonin reuptake inhibitor (SSRI) primarily used in the treatment of mood disorders.
Paroxyle 12.5 CR is effective in treating conditions like depression, anxiety, and obsessive-compulsive disorder (OCD). By increasing serotonin levels in the brain, Paroxyle helps improve mood, reduce anxiety, and alleviate symptoms of OCD. The prolonged-release formulation provides a steady effect, improving patient compliance and minimizing fluctuations in symptom control.
Common side effects include nausea, dizziness, dry mouth, and sexual dysfunction; serious side effects include suicidal thoughts and serotonin syndrome.
Indicated for major depressive disorder, generalized anxiety disorder, obsessive-compulsive disorder, panic disorder, and social anxiety disorder.
Take as prescribed by your doctor; do not exceed the recommended dose and avoid alcohol.
Store in a cool, dry place away from sunlight and moisture, out of reach of children. Important Notice:
Composition : Paroxetine I.P. 25mg Prolonged Release Tablets
Composition : Quetiapine Fumarate I.P. 100mg Tablet
Composition : Quetiapine Fumarate I.P. 25mg Tablet
Composition : Quetiapine Fumarate I.P. 50mg Tablet
Composition : Sertraline 100mg Tablet
Composition : Sertraline 25mg Tablet
Composition : Sertraline 50mg Tablet
Composition : Amisulpride 100mg Tablet
Composition : Amisulpride 200mg Tablet
Composition : Amisulpride (50mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Paroxetine Prolonged Release (PR) Tablets have strong demand in the psychiatry and CNS segment, making them a valuable low-dose maintenance product for pharma distributors, wholesalers, and franchise partners. It is widely prescribed for depression, anxiety disorders, panic disorder, and OCD, especially as a starting or maintenance therapy option.
Medical distributors and agencies benefit from the growing and consistent demand for psychiatric long-term therapy medicines. Used as a low-dose initiation or maintenance therapy in depression and anxiety disorders Effective in panic disorder, generalized anxiety disorder, and OCD Prolonged Release (PR) formulation helps in better tolerability and reduced side effects Widely prescribed by psychiatrists and general physicians Supports gradual dose titration and patient compliance Ensures steady monthly repeat prescriptions due to chronic use This makes it a stable, long-term CNS product with consistent demand.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Paroxetine 12.5 mg Prolonged Release Tablets with monopoly rights, promotional support, quality manufacturing standards, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and franchise partners benefit from consistent psychiatric prescription flow, strong demand in long-term mental health care, repeat monthly sales, and stable growth in the CNS therapeutic segment.
Interested distributors, stockists, and pharma franchise partners can contact Cafoli LifeCare Pvt Ltd to discuss monopoly territory rights, pricing structure, marketing support, and complete CNS product portfolio access to build a strong presence in the psychiatry and neurocare market.